# Han Chu Lee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/han-chu-lee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,310 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 64 |
| i10-index | 213 |
| Last Known Institution | Ulsan College |
| OpenAlex ID | https://openalex.org/A5018105181 |
| ORCID iD | https://orcid.org/0000-0002-7631-4124 |
| Works | 420 |

## Researcher papers

- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)
- [Genomic portrait of resectable hepatocellular carcinomas: Implications of <i>RB1</i> and <i>FGF19</i> aberrations for patient stratification](https://scholariq.org/papers/genomic-portrait-of-resectable-hepatocellular-carcinomas-implications-of-i-rb1-i/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Researcher university

- [Ulsan College](https://scholariq.org/institutions/ulsan-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.